C-MER Eye Care Holdings Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for C-MER Eye Care Holdings.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Healthcare earnings growth | 19.1% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 01 Sep 2023 |
Recent future growth updates
Recent updates
C-MER Eye Care Holdings' (HKG:3309) Earnings May Just Be The Starting Point
Apr 29C-MER Eye Care Holdings Limited's (HKG:3309) 26% Share Price Plunge Could Signal Some Risk
Feb 02C-MER Eye Care Holdings (HKG:3309) Might Be Having Difficulty Using Its Capital Effectively
Jan 17A Look At The Intrinsic Value Of C-MER Eye Care Holdings Limited (HKG:3309)
Apr 24Capital Allocation Trends At C-MER Eye Care Holdings (HKG:3309) Aren't Ideal
Dec 04Is C-MER Eye Care Holdings (HKG:3309) A Risky Investment?
Sep 22Update: C-MER Eye Care Holdings (HKG:3309) Stock Gained 25% In The Last Year
Dec 07Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2024 | 2,309 | 114 | 185 | 281 | 1 |
12/31/2023 | 1,924 | 62 | 245 | 361 | N/A |
9/30/2023 | 1,862 | 28 | 204 | 311 | N/A |
6/30/2023 | 1,801 | -7 | 162 | 261 | N/A |
3/31/2023 | 1,766 | -14 | 118 | 213 | N/A |
12/31/2022 | 1,732 | -22 | 74 | 165 | N/A |
9/30/2022 | 1,602 | 1 | 60 | 159 | N/A |
6/30/2022 | 1,473 | 23 | 45 | 154 | N/A |
3/31/2022 | 1,293 | 22 | 30 | 149 | N/A |
12/31/2021 | 1,113 | 22 | 15 | 144 | N/A |
9/30/2021 | 1,036 | 25 | 99 | 161 | N/A |
6/30/2021 | 959 | 28 | 184 | 178 | N/A |
3/31/2021 | 829 | 11 | 36 | 144 | N/A |
12/31/2020 | 700 | -6 | -111 | 110 | N/A |
9/30/2020 | 636 | -10 | -222 | 99 | N/A |
6/30/2020 | 573 | -13 | -334 | 88 | N/A |
3/31/2020 | 575 | 14 | -184 | 112 | N/A |
12/31/2019 | 576 | 41 | -35 | 137 | N/A |
9/30/2019 | 539 | 53 | 9 | 119 | N/A |
6/30/2019 | 502 | 64 | 53 | 102 | N/A |
3/31/2019 | 466 | 53 | 30 | 71 | N/A |
12/31/2018 | 429 | 43 | 7 | 41 | N/A |
9/30/2018 | 396 | 35 | -7 | 41 | N/A |
6/30/2018 | 363 | 27 | -21 | 41 | N/A |
3/31/2018 | 341 | 31 | -15 | 55 | N/A |
12/31/2017 | 311 | 40 | -1 | 65 | N/A |
9/30/2017 | 293 | 46 | N/A | 63 | N/A |
6/30/2017 | 274 | 52 | N/A | 60 | N/A |
3/31/2017 | 267 | 55 | N/A | 59 | N/A |
12/31/2016 | 249 | 47 | N/A | 53 | N/A |
12/31/2015 | 199 | 38 | N/A | 51 | N/A |
12/31/2014 | 156 | 22 | N/A | 43 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 3309's forecast earnings growth is above the savings rate (2.2%).
Earnings vs Market: Insufficient data to determine if 3309's earnings are forecast to grow faster than the Hong Kong market
High Growth Earnings: Insufficient data to determine if 3309's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 3309's revenue is forecast to grow faster than the Hong Kong market.
High Growth Revenue: Insufficient data to determine if 3309's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 3309's Return on Equity is forecast to be high in 3 years time